Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Eleveld TF"'
Autor:
Stavish D; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., Price CJ; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., Gelezauskaite G; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., Alsehli H; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., Leonhard KA; WiCell Research Institute, Madison, WI, USA., Taapken SM; WiCell Research Institute, Madison, WI, USA., McIntire EM; WiCell Research Institute, Madison, WI, USA; Department of Human Genetics, University of Chicago, Chicago, IL, USA., Laing O; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., James BM; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., Riley JJ; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK., Zerbib J; Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Baker D; Sheffield Diagnostic Genetic Services, Sheffield Children's Hospital, Sheffield, UK., Harding AL; School of Clinical Dentistry, University of Sheffield, Sheffield, UK., Jestice LH; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., Eleveld TF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Gillis AJM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Hillenius S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Looijenga LHJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Gokhale PJ; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK., Ben-David U; Department of Human Molecular Genetics and Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Ludwig TE; WiCell Research Institute, Madison, WI, USA; Office of the Vice Chancellor for Research and Graduate Education, University of Wisconsin-Madison, Madison, WI, USA., Barbaric I; Centre for Stem Cell Biology, School of Biosciences, The University of Sheffield, Sheffield, UK; Neuroscience Institute, The University of Sheffield, Sheffield, UK; INSIGNEO Institute, The University of Sheffield, Sheffield, UK. Electronic address: i.barbaric@sheffield.ac.uk.
Publikováno v:
Stem cell reports [Stem Cell Reports] 2024 Aug 13; Vol. 19 (8), pp. 1217-1232. Date of Electronic Publication: 2024 Jul 03.
Autor:
Eleveld TF; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands., Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Ebus ME; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Dandis R; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Caron HN; Hoffmann-La Roche, Basel, Switzerland., Koster J; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Eising S; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Versteeg R; Department of Oncogenomics, Amsterdam UMC, Amsterdam, Netherlands., Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pharmaceutical sciences, Utrecht University, Utrecht, Netherlands.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Feb 21; Vol. 13, pp. 1130034. Date of Electronic Publication: 2023 Feb 21 (Print Publication: 2023).
Autor:
Keller KM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Eleveld TF; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Schild L; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van den Handel K; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van den Boogaard M; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Amo-Addae V; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Eising S; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Ober K; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Koopmans B; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Looijenga L; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Tytgat GAM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Ylstra B; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands., Molenaar JJ; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Department of Pharmaceutical Sciences, University Utrecht, Utrecht, Netherlands., Dolman MEM; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia.; School of Women's and Children's Health, Faculty of Medicine, UNSW Sydney, Kensington, NSW, Australia., van Hooff SR; Department of Research, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Sep 27; Vol. 12, pp. 929123. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Autor:
Timmerman DM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Eleveld TF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Sriram S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Dorssers LCJ; Department of Pathology, Lab for Exp Patho-Oncology (LEPO), Erasmus MC-University Medical Center Rotterdam, Cancer Institute, Rotterdam, the Netherlands., Gillis AJM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Schmidtova S; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia., Kalavska K; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Second Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia., van de Werken HJG; Cancer Computational Biology Center, Department of Urology & Department of Immunology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, the Netherlands., Oing C; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCs4, University Cancer Center Hamburg, University Medical Center Eppendorf, Hamburg, Germany., Honecker F; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Eppendorf, Hamburg, Germany.; Tumor- and Breast Center ZeTuP, Sankt Gallen, Switzerland., Mego M; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.; Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia.; Second Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia., Looijenga LHJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Sep 10; Vol. 40 (26), pp. 3077-3087. Date of Electronic Publication: 2022 Apr 20.
Autor:
Eleveld TF; Department of Pathology, Cancer CenterAmsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Bakali C; Department of Pathology, Cancer CenterAmsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Eijk PP; Department of Pathology, Cancer CenterAmsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Stathi P; Department of Pathology, Cancer CenterAmsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Vriend LE; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Poddighe PJ; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands., Ylstra B; Department of Pathology, Cancer CenterAmsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
Publikováno v:
Nucleic acids research [Nucleic Acids Res] 2021 Dec 02; Vol. 49 (21), pp. 12007-12016.
Autor:
Timmerman DM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Eleveld TF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Gillis AJM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Friedrichs CC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Hillenius S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Remmers TL; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Sriram S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands., Looijenga LHJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS Utrecht, The Netherlands.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 29; Vol. 22 (21). Date of Electronic Publication: 2021 Oct 29.
Autor:
Hulsker CCC; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Kranendonk MEG; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.; Department of Pathology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Eleveld TF; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Gillis AJM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van de Ven CP; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., van der Kaaij NP; Department of Cardiothoracic Surgery, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., van der Steeg AFW; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands., Looijenga LHJ; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 27; Vol. 22 (17). Date of Electronic Publication: 2021 Aug 27.
Autor:
Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Lowery CD; Eli Lilly and Company, Indianapolis, IN, USA., Bergthold G; Hoffman-La Roche, Basel, Switzerland., Koster J; Department of Oncogenomics, Amsterdam University Medical Centre, Amsterdam, the Netherlands., Eleveld TF; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Rodríguez A; Hoffman-La Roche, Basel, Switzerland., Jones DTW; Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany., Vassal G; Department of Clinical Research, Gustave Roussy, Villejuif, France., Stancato LF; Eli Lilly and Company, Indianapolis, IN, USA., Pfister SM; Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg University Hospital, Heidelberg, Germany., Caron HN; Hoffman-La Roche, Basel, Switzerland., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 May; Vol. 130, pp. 168-181. Date of Electronic Publication: 2020 Mar 27.
Autor:
Eleveld TF; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands. t.f.eleveld@prinsesmaximacentrum.nl.; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Schild L; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands., Koster J; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Zwijnenburg DA; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Alles LK; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands., Ebus ME; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands., Volckmann R; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Tijtgat GA; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., van Sluis P; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Versteeg R; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Molenaar JJ; Department of Translational Research, Princess Maxima Centre for Childhood Oncology, Utrecht, the Netherlands.
Publikováno v:
Cancer research [Cancer Res] 2018 Nov 01; Vol. 78 (21), pp. 6297-6307. Date of Electronic Publication: 2018 Aug 16.
Autor:
Eleveld TF; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Oldridge DA; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bernard V; ICGEX Platform, Institut Curie, Paris, France., Koster J; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Colmet Daage L; 1] ICGEX Platform, Institut Curie, Paris, France. [2] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France., Diskin SJ; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schild L; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Bentahar NB; ICGEX Platform, Institut Curie, Paris, France., Bellini A; Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France., Chicard M; Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France., Lapouble E; Unité de Génétique Somatique, Institut Curie, Paris, France., Combaret V; Centre Léon-Bérard, Laboratoire de Recherche Translationnelle Lyon, Lyon, France., Legoix-Né P; ICGEX Platform, Institut Curie, Paris, France., Michon J; Département de Pédiatrie, Institut Curie, Paris, France., Pugh TJ; Princess Margaret Cancer Centre, University Health Network; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Hart LS; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Rader J; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Attiyeh EF; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wei JS; Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA., Zhang S; Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA., Naranjo A; Department of Biostatistics, University of Florida, Children's Oncology Group (COG), Gainesville, Florida, USA., Gastier-Foster JM; 1] The Ohio State University College of Medicine, Columbus, Ohio, USA. [2] Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA., Hogarty MD; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Asgharzadeh S; 1] Division of Hematology/Oncology, Children's Hospital Los Angeles, Los Angeles, California, USA. [2] Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, USA. [3] Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Smith MA; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA., Guidry Auvil JM; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA., Watkins TB; Translational Cancer Therapeutics Laboratory, Cancer Research UK, London, UK., Zwijnenburg DA; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Ebus ME; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., van Sluis P; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Hakkert A; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., van Wezel E; 1] Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands. [2] Landsteiner Laboratory, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., van der Schoot CE; 1] Department of Experimental Immunohematology, Sanquin Research, Amsterdam, the Netherlands. [2] Landsteiner Laboratory, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Westerhout EM; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Schulte JH; 1] Department of Pediatric Oncology and Hematology, Charité University Medicine, Berlin, Germany. [2] German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. [3] Department of Pediatric Oncology and Hematology, University Children's Hospital Essen, Essen, Germany. [4] Translational Neuro-Oncology, West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany., Tytgat GA; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Dolman ME; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Janoueix-Lerosey I; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France., Gerhard DS; Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA., Caron HN; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Delattre O; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France., Khan J; Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, US National Institutes of Health, Gaithersburg, Maryland, USA., Versteeg R; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Schleiermacher G; 1] Laboratory RTOP (Recherche Translationelle en Oncologie Pédiatrique), Transfer Department, Institut Curie, Paris, France. [2] Département de Pédiatrie, Institut Curie, Paris, France. [3] INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France., Molenaar JJ; Department of Oncogenomics, Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands., Maris JM; 1] Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [2] Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. [3] Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Nature genetics [Nat Genet] 2015 Aug; Vol. 47 (8), pp. 864-71. Date of Electronic Publication: 2015 Jun 29.